Donna M. Huryn
Donna M. Huryn received her B.A. (Chemistry) from Cornell University, and Ph.D. in Organic Chemistry from the University of Pennsylvania. After graduate school, she joined the Chemistry Research Department at Hoffmann-La Roche, Inc., and contributed to drug discovery efforts in inflammation, HIV and cancer with increasing levels of responsibility.
In 1997 she moved to Wyeth Research’s Chemical Sciences department. She held a number of positions there, including Director of CNS Medicinal Chemistry and Director of the Chemical Sciences Interface Department. Under her leadership, compounds entered clinical trials for asthma, Alzheimer’s disease, schizophrenia and depression.
In 2004, she left the pharmaceutical industry to join academia. She is on the faculty at the University of Pittsburgh’s School of Pharmacy, and holds an adjunct appointment in the Department of Chemistry at the University of Pennsylvania. She is a Fellow of the American Chemical Society, recipient of the ACS Philadelphia Local Section Award, has held a number of elected positions within the American Chemical Society at both the local and national levels, including Chair of the Division of Organic Chemistry. She is Associate Editor of ACS Medicinal Chemistry Letters, and on the Editorial Board of Organic Reactions. Professor Huryn’s research focuses on the design and synthesis of small molecules probes and drugs to treat cancer, neurodegenerative and infectious diseases.